BioPlus Acquisition Corp.
BIOSDelisted Oct 6, 2023- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001856653
BioPlus Acquisition Corp. was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $135.2M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding BioPlus Acquisition Corp. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 65 | 67 | +2 |
| Shares | 19.3M | 20.1M | +802.3K (+4.2%) |
| Value | $192.8M | $201.7M | +$8.95M (+4.6%) |
New holders (8)
Institutions that held BioPlus Acquisition Corp. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atalaya Capital Management LP | 250,000 | $2.51M | 0.34% |
| Aristeia Capital LLC | 232,256 | $2.33M | 0.04% |
| Parallax Volatility Advisers, L.P. | 221,829 | $2.23M | 0.04% |
| Spartan Fund Management Inc. | 149,285 | $1.50M | 0.46% |
| Wolverine Asset Management LLC | 40,270 | $404.0K | 0.01% |
| Karpus Management, Inc. | 34,135 | $342.0K | 0.01% |
| Clear Street LLC | 1,116 | $11.0K | 0.00% |
| Elequin Capital LP | 506 | $5.00K | 0.00% |
Sold out (6)
Institutions that held BioPlus Acquisition Corp. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Mangrove Partners | 405,141 | $4.03M |
| Weiss Asset Management LP | 205,000 | $2.06M |
| Basso Capital Management, L.P. | 145,001 | $1.44M |
| Union Square Park Capital Management, LLC | 50,000 | $499.0K |
| Eisler Capital (UK) Ltd. | 49,895 | $496.0K |
| Schonfeld Strategic Advisors LLC | 10,000 | $100.0K |